In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Several CRISPR-Cas9 orthologues have been used for genome editing. Here, we present the smallest Cas9 orthologue characterized to date, derived from Campylobacter jejuni (CjCas9), for efficient genome editing in vivo . After determining protospacer-adjacent motif (PAM) sequences and optimizing single-guide RNA (sgRNA) length, we package the CjCas9 gene, its sgRNA sequence, and a marker gene in an all-in-one adeno-associated virus (AAV) vector and produce the resulting virus at a high titer. CjCas9 is highly specific, cleaving only a limited number of sites in the human or mouse genome. CjCas9, delivered via AAV, induces targeted mutations at high frequencies in mouse muscle cells or retinal pigment epithelium (RPE) cells. Furthermore, CjCas9 targeted to the Vegfa or Hif1a gene in RPE cells reduces the size of laser-induced choroidal neovascularization, suggesting that in vivo genome editing with CjCas9 is a new option for the treatment of age-related macular degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Smaller genome editing proteins, such as the S. aureus Cas9, C. jejuni Cas9 and newly identified CRISPR-Cas enzymes, may circumvent this issue 23,61-65 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The downregulation was linked to a decrease in spot size on morphology of the laser-induced choroidal neovascularization (wet AMD model) but not on retinal function measured by electroretinogram (ERG) [221].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [221]
The cited source says what the claim attributes to it.
In the citing paper
“Fonfara et al. previously reported the optimal in vitro PAM site for CjCas9 to be 5′-NNNNACA”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [72]
The cited source says what the claim attributes to it.
In the citing paper
“In February 2017, Kim et al. presented efficient in vivo genome editing using the smallest Cas9 orthologue (2.95 kb) that has been characterized as of February 2017: Campylobacter jejuni (CjCas9) [72].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [72]
The cited source says what the claim attributes to it.
In the citing paper
“In February 2017, Kim et al. presented efficient in vivo genome editing using the smallest Cas9 orthologue (2.95 kb) that has been characterized as of February 2017: Campylobacter jejuni (CjCas9) [72].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [72]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Bae, S., Park, J., & Kim, J.-S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu048 · Cited by 2,339
Self-citationRNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
Self-citationStructural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
Anders, C., Niewoehner, O., Duerst, A., & Jinek, M. (2014) · Nature · doi:10.1038/nature13579 · Cited by 1,323
Cited by
Items 501–600 of 730
Versatile and efficient genome editing with Neisseria cinerea Cas9
Liu, Z., Chen, S., Xie, W., Yu, H., Lai, L., & Li, Z. (2022) · Communications Biology · doi:10.1038/s42003-022-04258-z · Cited by 7
In vivo treatment of tyrosinaemia with hypercompact Cas12f1
Guo, R., Li, Z., Li, G., Zhang, H., Zhang, C., Huo, X., Zhang, X., Yang, X., Yang, R., Liu, Y., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00554-y · Cited by 7
Efficient and specific generation of knockout mice using Campylobacter jejuni CRISPR/Cas9 system
Lee, J. Y., Jang, Y. J., Bae, J. H., Lee, Y. H., Bae, H. S., Kim, S., Park, S.-G., Koo, O. J., & Yeom, S. C. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100752 · Cited by 7
Self-citationGuarding the genome: strategies for off-target detection and minimization in CRISPR/Cas9 system
Lotfi, M., Yazdi, Z. F., Hashemi, M. R., Abbaszadegan, M. R., & Sharif, S. (2025) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2025.2581677 · Cited by 8
The Promise and Pitfalls of AAV-Mediated Gene Therapy for Duchenne Muscular Dystrophy
Kurshakova, E. V., Levchenko, O. A., Smirnikhina, S., & Лавров, А. В. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47121058 · Cited by 6
Qi, C., Shen, X., Li, B., Liu, C., Huang, L., Lan, H., Chen, D., Jiang, Y., & Wang, D. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.10.014 · Cited by 6
Recent Advances in CRISPR/Cas9 Technology for Engineering Disease Resistance in Plants
Bhalerao, S., Okoń, S., Rai, M. K., Jadhav, P., & Prokisch, J. (2025) · Acta Agrobotanica · doi:10.5586/aa/201389 · Cited by 8
Efficient Generation of Genome-Modified Mice Using Campylobacter jejuni-Derived CRISPR/Cas
Fujii, W., Ikeda, A., Sugiura, K., & Naito, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112286 · Cited by 6
Viral delivery of genome-modifying proteins for cellular reprogramming
Mikkelsen, J. G. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.06.005 · Cited by 7
Expanding the CRISPR/Cas genome-editing scope in Xenopus tropicalis
Shi, Z., Jiang, H., Liu, G., Shi, S., Zhang, X., & Chen, Y. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00841-3 · Cited by 6
Deciphering the Role of CRISPR/Cas9 in the Amelioration of Abiotic and Biotic Stress Conditions
Singh, S., Chaudhary, R., Chaturvedi, S., & Tiwari, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-8529-6_8 · Cited by 6
Gene editing of angiotensin for blood pressure management
Masi, S., Dalpiaz, H., & Borghi, C. (2024) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2024.200323 · Cited by 7
Genetically Modified Animal-Derived Products: From Regulations to Applications
Fajardo, C., Macedo, M., Buha, T., Donato, M. D., Costas, B., & Mancera, J. M. (2025) · Animals · doi:10.3390/ani15111570 · Cited by 10
CRISPR-SCReT (CRISPR-Stop Codon Read Through) method to control Cas9 expression for gene editing
Yaméogo, P., Duchêne, B. L., Majeau, N., & Tremblay, J. P. (2021) · Gene Therapy · doi:10.1038/s41434-021-00297-z · Cited by 7
Gene and epigenetic editing in the treatment of primary ciliopathies
Molinari, E., & Sayer, J. A. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.027 · Cited by 7
Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad?
Ceballos-Garzón, A., Muñoz, A. B., Plata, J. D., Sánchez-Quitian, Z. A., & Ramos-Vivas, J. (2022) · Pathogens and Disease · doi:10.1093/femspd/ftac039 · Cited by 9
Omura, S. N., & Nureki, O. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.01.052 · Cited by 6
Gene therapy in neovascular age related macular degeneration: an update
Quesada, E., Vázquez, S. R., Campos, X., & Wu, L. (2025) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-025-06837-2 · Cited by 5
Yu, M., Ai, L., Wang, B., Lian, S., Ip, L., Liu, J., Li, L. X., Tsai, S. Q., Kleinstiver, B. P., & Zheng, Z. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01464-y · Cited by 6
Barragán-Álvarez, C. P., Flores-Fernández, J. M., Hernández‐Pérez, O. R., Ávila‐González, D., Díaz, N. F., Padilla‐Camberos, E., Dublán‐García, O., Gómez‐Oliván, L. M., & Diaz-Martinez, N. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.947769 · Cited by 6
Engineered Staphylococcus auricularis Cas9 with high‐fidelity
Wei, N., Shang, L., Liu, J., Wang, M., Liu, Y., Zhu, C., Fei, C., Zhang, L., Yang, F., & Gu, F. (2023) · The FASEB Journal · doi:10.1096/fj.202202132rr · Cited by 6
Developing small Cas9 hybrids using molecular modeling
Mangin, A., Dion, V., & Menzies, G. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-68107-1 · Cited by 6
Advancing CRISPR base editing technology through innovative strategies and ideas
Fan, X., Lei, Y., Wang, L., Wu, X., & Li, D. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2699-5 · Cited by 6
Fehrman, R. L., Chern, K. J., Stoltz, K. P., & Lipinski, D. M. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110223 · Cited by 5
Belato, H. B., Knight, A. L., D’Ordine, A. M., Pindi, C., Fan, Z.-Q., Luo, J., Palermo, G., Jogl, G., & Lisi, G. P. (2024) · eLife · doi:10.7554/elife.99275.4 · Cited by 5
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Liu, K. I., Sutrisnoh, N.-A. B., Wang, Y., & Tan, M. H. (2019) · Journal of Visualized Experiments · doi:10.3791/59086 · Cited by 5
The applications of CRISPR/Cas-mediated genome editing in genetic hearing loss
Wu, J., Tao, Y., Deng, D., Meng, Z., & Zhao, Y. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01021-7 · Cited by 5
CRISPR-ERA for Switching Off (Onco) Genes
García‐Tuñón, I., Vuelta, E., Pérez‐Ramos, S., Hernández‐Rivas, J. M., Méndez, L., Herrero, M., & Sánchez‐Martín, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80245 · Cited by 5
The Synergy between CRISPR and Chemical Engineering
Lau, C., & Tin, C. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190701100556 · Cited by 5
Efficient Genome and Base Editing in Human Cells Using ThermoCas9
Trasanidou, D., Barendse, P., Bouzetos, E., de Haan, L., Bouwmeester, H., Staals, R. H. J., Mougiakos, I., & John van der, O. O. S. T. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0005 · Cited by 5
Xin, C., Xiang, G., Cao, S., Wang, Y., Yuan, S., Liu, X., Huo, Y., Sun, J., Wan, X., Liu, D., et al. (2026) · Genome biology · doi:10.1186/s13059-026-03949-8 · Cited by 4
Application and Research Prospects of CRISPR/Cas Gene Editing Technology in Lactic Acid Bacteria
张二红, Yan, J., Du, J., Chu, X., & Chen, D. (2026) · Microorganisms · doi:10.3390/microorganisms14040739 · Cited by 4
Genome Editing for Improvement of Nutrition and Quality in Vegetable Crops
Gupta, P., Karkute, S. G., Dash, P. K., & Singh, A. K. (2023) · Wiley eBooks · doi:10.1002/9781394183913.ch11 · Cited by 5
Engineering of SauriCas9 with enhanced specificity
Zhang, X., Tao, C., Li, M., Zhang, S., Liang, P., Huang, Y. H., Liu, H., & Wang, Y. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102455 · Cited by 4
Ramachandran, R. (2020) · Resonance · doi:10.1007/s12045-020-1088-6 · Cited by 4
Profiling Genome-Wide Specificity of CRISPR-Cas9 Using Digenome-Seq
Kim, D., & Kim, J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0687-2_13 · Cited by 5
Self-citationCRISPR-Cas epigenome editing: improving crop resistance to pathogens
López-Calleja, A. C., Vizuet‐de‐Rueda, J. C., & Álvarez-Venegas, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821910-2.00030-8 · Cited by 6
Esquerra‐Ruvira, B., Baquedano, I., Ruiz, R., Fernandez, A., Montoliu, L., & Mojica, F. J. M. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14266 · Cited by 4
Tang, N., Wu, Z., Gao, Y., Chen, W., Wang, Z., Su, M., Ji, W., & Ji, Q. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00501 · Cited by 4
The advances and challenges of Gene Therapy for Duchenne Muscular Dystrophy
Tremblay, J. P. (2017) · Journal of Genetic Medicine and Gene Therapy · doi:10.29328/journal.jgmgt.1001003 · Cited by 6
Wang, Q., Bian, X., Du, J., Lv, Y., Tao, L., & Xie, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.01.442224 · Cited by 4
How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research
Rivera, F. J. S., & Dow, L. E. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041384 · Cited by 6
Nammi, B., Jayasinghe‐Arachchige, V. M., Madugula, S. S., Artiles, M., Radler, C. N., Pham, T. T., Liu, J., & Wang, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.28.640911 · Cited by 4
Novel approach to antiangiogenic factors in age-related macular degeneration therapy
Samelska, K., Kupis, M., Izdebska, J., Kamińska, A., & Skopiński, P. (2022) · Central European Journal of Immunology · doi:10.5114/ceji.2022.113103 · Cited by 3
All-in-one AAV-mediated Nrl gene inactivation rescues retinal degeneration in Pde6a mice
Liu, Z., Chen, S., Lo, C., Wang, Q. K., & Sun, Y. (2024) · JCI Insight · doi:10.1172/jci.insight.178159 · Cited by 4
Park, H. J., Kim, J., Choi, J., Ryou, C., Shin, E., & Lee, J. (2025) · Autophagy · doi:10.1080/15548627.2025.2569965 · Cited by 5
Self-citationWu, J., Jang, H., Kwak, H., Son, M., Jiang, W., Hwang, H., Jo, D. H., Kim, D., Kim, S., & Kim, J. H. (2025) · Genome biology · doi:10.1186/s13059-025-03774-5 · Cited by 3
Self-citationAnti-CRISPR protein AcrIIA5 can enhance the activity and security of prime editing
Chen, Q., Jiang, X., Yang, B., Deng, Z., & Sun, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-66237-2 · Cited by 4
Structural visualization of the molecular evolution of CRISPR–Cas9
Nagahata, N., Kato, K., Yamada, S., Kannan, S., Okazaki, S., Isayama, Y., Hiraizumi, M., Yamashita, K., Koonin, E. V., Zhang, F., et al. (2026) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01743-x · Cited by 4
In vivo delivery strategies for therapeutic CRISPR genome editing
Martin, L., Bohinc, J., Recchia, A., Gritti, S., Santilli, G., Zeyland, J., Vidaković, M., Grdović, N., Benabdellah, K., Ortiz-Bueno, M., et al. (2026) · International Journal of Biological Sciences · doi:10.7150/ijbs.133162 · Cited by 3
Taemaitree, L., Shivalingam, A., El-Sagheer, A. H., & Brown, T. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0687-2_5 · Cited by 3
Characterization of NiCas12b for In Vivo Genome Editing
Zhang, Y., Wei, J., Wang, H., & Wang, Y. (2024) · Advanced Science · doi:10.1002/advs.202400469 · Cited by 3
Analysis of metal-dependent DNA nicking activities by Cas endonucleases
Nguyen, G. T., Raju, A., & Sashital, D. G. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.01.034 · Cited by 3
Efforts to Downsize Base Editors for Clinical Applications
Song, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052357 · Cited by 3
Tissue-culture free gene editing in plants using virus-induced gene editing: a brief overview
Chauhan, H., Alok, A., & Singh, K. (2025) · The Nucleus · doi:10.1007/s13237-025-00562-1 · Cited by 3
Induced mutagenesis in wheat: from ionizing radiation to site-specific gene editing
Kishchenko, O., Stepanenko, A., & Borisjuk, N. V. (2021) · Fiziologia rastenij i genetika · doi:10.15407/frg2021.01.029 · Cited by 4
Highly Multiplexed Analysis of CRISPR Genome Editing Outcomes in Mammalian Cells
Ishiguro, S., & Yachie, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1441-9_12 · Cited by 3
Tapping into the Unsung Potential of CRISPR/CAS Technology in Agriculture
Rehman, R. S., Ali, M., Zafar, S. A., Ahmad, M., Pasha, A. N., Bashir, H., Rashid, F., & Hussain, M. (2022) · Asian Journal of Biochemistry Genetics and Molecular Biology · doi:10.9734/ajbgmb/2022/v10i430249 · Cited by 5
Bellingrath, J.-S., McClements, M. E., Shanks, M. E., Clouston, P., Fischer, M. D., & MacLaren, R. E. (2022) · Ophthalmic Genetics · doi:10.1080/13816810.2022.2073599 · Cited by 3
Long-Term Evaluation of Retinal Morphology and Function in Rosa26-Cas9 Knock-In Mice
Mohan, K., Dubey, S. K., Jung, K., Dubey, R., Wang, Q. J., Prajapati, S. C., Roney, J., Abney, J., & Kleinman, M. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065186 · Cited by 3
Characterization of CoCas9 nuclease from Capnocytophaga ochracea
Vasileva, A., Selkova, P., Arseniev, A. S., Abramova, M., Shcheglova, N., Musharova, O. S., Мизгирев, И. В., Артамонова, Т. О., Khodorkovskii, M. A., Severinov, K., et al. (2023) · RNA Biology · doi:10.1080/15476286.2023.2256578 · Cited by 3
Structure and engineering of Brevibacillus laterosporus Cas9
Nakane, T., Nakagawa, R., Ishiguro, S., Okazaki, S., Mori, H., Shuto, Y., Yamashita, K., Yachie, N., Nishimasu, H., & Nureki, O. (2024) · Communications Biology · doi:10.1038/s42003-024-06422-z · Cited by 3
Enhanced genome editing with a Streptococcus equinus Cas9
Liu, J., Wang, Y., Wei, J., Wang, S., Li, M., Huang, Z., Zhang, S., Liu, H., Huang, J., & Wang, Y. (2025) · Communications Biology · doi:10.1038/s42003-025-07593-z · Cited by 4
Design of Muscle Gene Therapy Expression Cassette
Lai, Y., & Duan, D. (2019) · Springer eBooks · doi:10.1007/978-3-030-03095-7_8 · Cited by 3
Induced mutagenesis to sustain wheat production under changing climate
Bakshi, S., Jambhulkar, S. J., Kumar, U., & Bhati, P. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821316-2.00003-0 · Cited by 3
Muscular Dystrophy Therapy Using Viral Vector-based CRISPR/Cas
Choi, E., & Koo, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_4 · Cited by 3
Self-citationVersatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9Preprint
Agudelo, D., Carter, S., Velimirovic, M., Duringer, A., Levesque, S., Rivest, J.-F., Loehr, J., Mouchiroud, M., Cyr, D., Waters, P. J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/321208 · Cited by 3
One Anti-CRISPR to Rule Them All: Potent Inhibition of Cas9 Homologs Used for Genome EditingPreprint
García, B., Lee, J., Edraki, A., Hidalgo-Reyes, Y., Erwood, S., Mir, A., Trost, C. N., Seroussi, U., Stanley, S. Y., Cohn, R. D., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3385124 · Cited by 3
Omura, S. N., Nakagawa, R., Kajimoto, S., Okazaki, S., Ishiguro, S., Mori, H., Onishi, K., Kashiwakura, Y., Hiramoto, T., Horinaka, K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71626-2 · Cited by 2
“WhileSpCas9ef fi ciently cleavesitstargetDNAusinga20-nt guide sgRNA, most small Cas9 orthologs require 1 – 2-nt longer guides for ef fi cient DNA cleavage (e.g., 21-and 22-nt guides are optimal for SaCas9andCjCas9,respectively) 1,11,38,39 .”
Designer nucleases to treat malignant cancers driven by viral oncogenes
Scott, T. A., & Morris, K. V. (2021) · Virology Journal · doi:10.1186/s12985-021-01488-1 · Cited by 2
Crafting Genetic Diversity: Unlocking the Potential of Protein Evolution
Gali, V. K., Tee, K. L., & Wong, T. S. (2024) · SynBio · doi:10.3390/synbio2020009 · Cited by 2
Wang, Q., Wang, Z., Liu, H., Lv, Y., Zhou, C., Li, C., Fan, H.-Q., Ouyang, X., Tao, L., Pei, X., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08984-y · Cited by 2
Fehrman, R. L., & Lipinski, D. M. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.11.38 · Cited by 2
Dissecting cellular ecosystem with single-cell CRISPR screens
Liu, Z., Lan, Z., Kang, X., Yao, Y., & Rao, S. (2025) · Blood Science · doi:10.1097/bs9.0000000000000266 · Cited by 2
CRISPR-Cas9 Gene Editing in Aspergillus: From Pathogenesis to Metabolic Engineering
Hu, D., Zhao, R., Lin, Y., & Jiang, C. (2025) · Biology · doi:10.3390/biology15010053 · Cited by 4
CRISPR in the Tumor Microenvironment: From Diagnostic Profiling to Precision Therapy
Zhou, L., Mu, M., Yang, M., Liu, X., Zou, G., & Liu, C. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i1.12 · Cited by 2
Cho, E., Lee, J., Kim, J., Choi, J., Kang, M., & Song, J. (2026) · Journal of Biological Engineering · doi:10.1186/s13036-026-00673-6 · Cited by 3
Self-citationCRISPR and the Future of Cardiac Disease Therapy: A New Genetic Frontier
Sterckel, S., Martínez, I. L. C., & Schwach, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083641 · Cited by 2
Siddika, A., Rousseau, J., Veillette, F., Bouchard, C., Lu, Y., & Tremblay, J. P. (2026) · Cells · doi:10.3390/cells15100852 · Cited by 2
CRISPR-based gene editing for antimicrobial resistance control in human medicine
Alvi, A. A., Hussain, M., Noureen, S., Malik, Z. A., Zahoor, S., Jamil, A., Mohsin, M. A., Azeem, A., Javaid, H., & Hassan, Z. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-04988-2 · Cited by 3
She, L., Liang, Z., Zou, Q., & Huo, Y. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.6c00386 · Cited by 2
Protein Engineering of DNA-Dependent Enzymes
Yudkina, A. V., & Zharkov, D. O. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-41283-8_2 · Cited by 2
CRISPR-Cas orthologs and variants
Scollan, M. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817876-8.00008-5 · Cited by 3
CRISPR-Cas-Based Gene Therapy to Target Viral Infections
Hussein, M., Berkhout, B., & Herrera-Carrillo, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_5 · Cited by 2
Small-molecule inhibitors of proteasome increase CjCas9 protein stability
Yaméogo, P., Majeau, N., Mbakam, C. H., & Tremblay, J. P. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280353 · Cited by 2
Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli
Trasanidou, D., Potocnik, A., Barendse, P., Mohanraju, P., Bouzetos, E., Karpouzis, E., Desmet, A., van Kranenburg, R., John van der, O. O. S. T., Staals, R. H. J., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05418-5 · Cited by 2
CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
Xie, D., Chen, Y., Hu, S., Huang, L., & Huang, J. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.278 · Cited by 2
Targeting the IDH1R132H mutation in gliomas by CRISPR/Cas precision base editing
Weber, R., Vasella, F., Klimko, A., Silginer, M., Lamfers, M. L. M., Neidert, M. C., Regli, L., Schwank, G., & Weller, M. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae182 · Cited by 4
Ebner, L. J. A., Imsand, C., Karademir, D., Peters, F., Kiessling, E., Fottner, A., Matter, C., Fajardo, D. S., Merolla, L., Wögenstein, G. M., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.044 · Cited by 2
Gene Therapy for Facioscapulohumeral Muscular Dystrophy (FSHD)
Miller, D. G. (2019) · Springer eBooks · doi:10.1007/978-3-030-03095-7_29 · Cited by 2
Stieger, K., & Lorenz, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-28384-1_15 · Cited by 2
CRISPR-Cas9 for therapy: the challenges and ways to overcome them
Acharya, S., Maiti, S., & Chakraborty, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818140-9.00009-x · Cited by 3
Lek, A., Ma, K., Woodman, K. G., & Lek, M. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.241 · Cited by 3
CRISPR based development of RNA editing and the diagnostic platform
Satish, L., Gunamalai, L., Kasthuri, T., Kalaivaani, A., Shamili, S., Muthuramalingam, P., Gowrishankar, S., Pandian, S. K., Singh, V., Sitrit, Y., et al. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.015 · Cited by 2
The history of CRISPR: from discovery to the present
Xu, C. L., & Tsang, S. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817876-8.00007-3 · Cited by 4
CRISPR/Cas System and Stem Cell Editing: Prospects and Possibilities in Veterinary Sciences
Hussain, M. S., & Kumar, M. (2021) · Springer eBooks · doi:10.1007/978-981-16-3464-2_18 · Cited by 2
Kim, M., & Yu, H. G. (2022) · Springer eBooks · doi:10.1007/978-981-16-7337-5_8 · Cited by 3
Robust Genome Editing of Single-Base PAM Targets with Engineered ScCas9 VariantsPreprint
Chatterjee, P., Jakimo, N., & Jacobson, J. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/620351 · Cited by 2
Correcting reference bias from the Illumina Isaac aligner enables analysis of cancer genomesPreprint
Cornish, A. J., Chubb, D., Frangou, A., Hoang, P. H., Kaiser, M., Wedge, D. C., & Houlston, R. S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/836171 · Cited by 2
Establishing a human cell-based model system for macular degeneration
Neiteler, A. (2019) · ERA · doi:10.7488/era/8 · Cited by 3
Metadata
- Authors
- Kim, E., Koo, T., Park, S. W., Kim, D., Kim, K., Cho, H.-Y., Song, D. W., Lee, K. J., Jung, M. H., Kim, S., Kim, J. H., Kim, J. H., & Kim, J.-S.
- Affiliations
- Institute for Basic Science (KR)
- Seoul National University (KR)
- ToolGen (South Korea) (KR)
- Corresponding author
- Kim, Jeong Hun
- ORCID
- Venue
- Nature Communications
- Published
- 2017-02-21
- Volume
- 8
- Issue
- 1
- Pages
- 14500-14500
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5473640
- OpenAlex
- W2590764628
- Cited by
- 715
- References
- 38
- Citations by year
- 2026: 24 · 2025: 68 · 2024: 68 · 2023: 81 · 2022: 114 · 2021: 94 · 2020: 87 · 2019: 77 · 2018: 66 · 2017: 36
- FWCI
- 29.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- National Research Foundation (NRF-2015M3A9E6028949)
- Ministry of Science, ICT and Future Planning (NRF-2015M3A9E6028949, IBS-R021-D1, 2015M3A9E6028949)
- Korea Health Industry Development Institute (HI16C0426)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- in vivo gene editing, adeno-associated virus vectors, single guide RNA, protospacer adjacent motif, retinal pigment epithelium, choroidal neovascularization, age-related macular degeneration, VEGF-A, HIF1A, targeted mutagenesis
- MeSH terms
- Gene Editing, Dependovirus, Animals, Bacterial Proteins, Cells, Cultured, Endonucleases, Humans, Male, Mice, Inbred C57BL, Campylobacter jejuni, Choroidal Neovascularization, Vascular Endothelial Growth Factor A, Retinal Pigment Epithelium, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.